You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Use of Antihypertensive Drugs During Preeclampsia
|
|---|---|
| Published in |
Frontiers in Cardiovascular Medicine, May 2018
|
| DOI | 10.3389/fcvm.2018.00050 |
| Pubmed ID | |
| Authors |
Obinnaya Odigboegwu, Lu J. Pan, Piyali Chatterjee |
| Abstract |
Treatment of pregnancy-related hypertensive disorders, such as preeclampsia (PE), remain a challenging problem in obstetrics. Typically, aggressive antihypertensive drug treatment options are avoided to prevent pharmacological-induced hypotension. Another major concern of administering antihypertensive drugs during pregnancy is possible adverse fetal outcome. In addition, management of hypertension during pregnancy in chronic hypertensive patients or in patients with prior kidney problems are carefully considered. Recent studies suggest that PE patients are at increased cardiovascular risk postpartum. Therefore, these patients need to be monitored postpartum for the subsequent development of other cardiovascular diseases. In this review article, we review the antihypertensive drugs currently being used to treat patients with PE and the advantages or disadvantages of using these drugs during pregnancy. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 183 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 27 | 15% |
| Other | 12 | 7% |
| Student > Master | 11 | 6% |
| Student > Ph. D. Student | 8 | 4% |
| Student > Doctoral Student | 5 | 3% |
| Other | 20 | 11% |
| Unknown | 100 | 55% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 21% |
| Nursing and Health Professions | 10 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 5% |
| Biochemistry, Genetics and Molecular Biology | 8 | 4% |
| Unspecified | 4 | 2% |
| Other | 13 | 7% |
| Unknown | 99 | 54% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2018.
All research outputs
#14,409,968
of 23,081,466 outputs
Outputs from Frontiers in Cardiovascular Medicine
#1,895
of 6,992 outputs
Outputs of similar age
#187,595
of 331,240 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#33
of 52 outputs
Altmetric has tracked 23,081,466 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,992 research outputs from this source. They receive a mean Attention Score of 4.2. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,240 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.